Delivery Order SPE2DB22D1106-SPE2DB25FFAD6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,738.12 to AmerisourceBergen Drug Corp for 100 capsules of Prograf 1 mg on September 11, 2025, with completion anticipated by September 12, 2025. This competitively awarded, firm fixed price contract involves no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Prograf (tacrolimus) is an immunosuppressant medication commonly used in organ transplant recipients and other...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,575 to Amerisourcebergen Drug Corporation for 100 capsules of the prescription medication Prograf. As the prime contractor, Amerisourcebergen will deliver the Prograf to a facility located in Conshohocken, Pennsylvania by September 15, 2023 under the terms of this order. Prograf is an immunosuppressant drug commonly used for transplant patients. This delivery order was issued against the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $41,735.37 to AmerisourceBergen Drug Corp for the supply of Prograf 5 mg capsules (100 count units) under a firm fixed price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award represents a competitively awarded transaction for a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,607.93 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units). This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive set-aside procurement. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $1,303.59 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Prograf 1 mg capsules (100-unit quantity). This firm fixed price contract, with an ultimate completion date of September 16, 2025, represents a non-set-aside competitive award to be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $1,393.41 delivery order to AmerisourceBergen Drug Corp for Prograf 5 mg/mL ampules, with an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,657.94 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Prograf 1 mg capsules in quantities of 100 units. This contract is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and was competitively awarded without set-aside designation. The award represents a child contract under a larger indefinite delivery contract...
- This is a $39,414.93 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for a quantity of 100 count Prograf 5 mg capsules, which are likely immunosuppressant medications used to prevent organ rejection in transplant patients. The order has a completion date of September 4, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical products and...
- The Defense Logistics Agency awarded a $1,738.12 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Prograf 1 mg capsules (100-count units). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,618,245 units of the prescription medication Prograf 1 mg capsules in 100-count bottles. The $1,690.50 firm fixed-price delivery order was awarded on May 15, 2024 with a completion date of May 16, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which provides logistics and acquisition support to the U.S. Department of Defense....
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAD6Delivery Order
The Defense Logistics Agency awarded a $18,879.92 delivery order to AmerisourceBergen Drug Corp for Prograf 1 mg capsules (100-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Prograf (tacrolimus) is an immunosuppressant medication commonly used in transplant medicine and autoimmune disease management, representing part of the Defense Logistics Agency's critical pharmaceutical supply requirements for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a prime vendor for the Defense Logistics Agency's global pharmaceutical support initiatives, supplying a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's competitive award of this delivery order reflects its established capability to meet federal procurement standards for medical supply delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.9k | 7/28/25 |